Search results for "methylphenidate"

showing 10 items of 30 documents

Learning to be a psychostimulants addict with self-regulation therapy

2018

This article presents the results of a single-case experiment of alternative treatments in which a participant applied the Self-Regulation Therapy (SRT) to reproduce the effects of a stimulant drug, methylphenidate, and a sedative, alcohol. The SRT is a learning procedure based on classic conditioning and suggestion that reproduces the effect of drugs by remembering the effects they have. The participant reproduced the effects of both drugs during ten sessions held on 5 consecutive days. To record effects, adjective scales were used that measured Drug effect, High, Rush, Energy, Tension and the General Factor of Personality (GFP). The results indicated that the participant was capable of in…

DrugPsychotherapistmedicine.drug_classmedia_common.quotation_subjectAddictionSelf-Regulation TherapyUNESCO::FILOSOFÍA:FILOSOFÍA [UNESCO]medicineInverted uDrug effectmedia_commonSensitization drugMethylphenidateClassical conditioningGeneral MedicineTerapèuticaGeneral Factor of PersonalityTolerance drugSedativeMethylphenidateDroguesPersonalitatStimulant drugPsychologyAlcoholMATEMATICA APLICADAMedicamentsmedicine.drug
researchProduct

Self-Regulation Therapy to Reproduce Drug Effects:A Suggestion Technique to Change Personality and theDRD3Gene Expression

2013

This study proposes a strategy, based on self-regulation therapy, to change personality and its biological substrate, the DRD3 gene expression. It has been demonstrated that acute doses of stimulating drugs, like methylphenidate, are able to change personality and the expression of certain genes in the short term. On the other hand, self-regulation therapy has been proven to reproduce the effects of drugs. Thus, it is feasible to hope that self-regulation therapy is equally effective as methylphenidate in changing personality and the gene expression. This is a preliminary study with a single-case experimental design with replication in which 2 subjects participated. The results and potentia…

MaleComplementary and Manual TherapyDrugHypnosisPsychotherapistPersonality InventoryC-Fosmedia_common.quotation_subjectGene ExpressionMessenger RNA expressionD-3 receptorGene expressionmedicineHumansPersonalityPeripheral blood lymphocytesSuggestionmedia_commonMethylphenidateReceptors Dopamine D3Middle AgedClinical PsychologyExpression (architecture)MethylphenidateCentral Nervous System StimulantsFemalesense organsDopamine receptor geneMATEMATICA APLICADAPsychologyPersonalitymedicine.drugInternational Journal of Clinical and Experimental Hypnosis
researchProduct

Impaired oral absorption of methylphenidate after Roux-en-Y gastric bypass

2017

The anatomic and physiologic changes in the gastrointestinal (GI) tract after bariatric surgery may significantly affect the pharmacokinetics of medications taken by the patients for various reasons. Unfortunately, there is little information regarding changes in drug absorption after bariatric surgeries, limiting the ability of medical professionals to produce clear recommendations on what changes should be made to the formulations and dosing regimens of drugs after bariatric surgery. In this article, we report and analyze a case of 52-year-old male patient with morbid obesity and attention-deficit/hyperactivity disorder (ADHD) who experienced lack of methylphenidate efficacy after Roux en…

MaleDrugmedicine.medical_specialtyTransdermal patchmedia_common.quotation_subjectGastric BypassAdministration Oral03 medical and health sciences0302 clinical medicinePharmacokinetics0502 economics and businessmedicineHumans030212 general & internal medicineDosingmedia_commonMethylphenidatebusiness.industry05 social sciencesMiddle Agedmedicine.diseaseObesityRoux-en-Y anastomosisObesity MorbidSurgeryAttention Deficit Disorder with HyperactivityGastrointestinal AbsorptionAnesthesiaToxicityMethylphenidateCentral Nervous System Stimulants050211 marketingSurgerybusinessmedicine.drugSurgery for Obesity and Related Diseases
researchProduct

Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists

2011

Rationale Impulsivity is associated with a number of psychiatric disorders, most notably attention deficit/hyperactivity disorder (ADHD). Drugs that augment catecholamine function (e.g. methylphenidate and the selective noradrenaline reuptake inhibitor atomoxetine) have clinical efficacy in ADHD, but their precise mechanism of action is unclear. Objective The objective of this study is to investigate the relative contribution of dopamine (DA) and noradrenaline (NA) to the therapeutic effects of clinically effective drugs in ADHD using rats selected for high impulsivity on the five-choice serial reaction time task (5CSRTT). Methods We examined the effects of direct and indirect DA and NA rec…

MaleImpulsivityQuinpiroleDopamineSerial LearningAtomoxetine HydrochlorideImpulsivityChoice BehaviorPiperazines03 medical and health sciences0302 clinical medicineQuinpiroleDopaminemental disordersAnimals Outbred StrainsReaction TimemedicineAnimalsAttentionOriginal InvestigationPharmacologyPropylaminesMethylphenidateDopaminergicAtomoxetineGBR-12909Adrenergic AgonistsGuanfacineRats030227 psychiatry3. Good healthGuanfacineSumaniroleFive-choice serial reaction time taskAtomoxetine; Dopamine; Five-choice serial reaction time task; GBR-12909; Guanfacine; Impulsivity; Methylphenidate; Noradrenaline; Quinpirole; Sumanirole; Adrenergic Agonists; Animals; Animals Outbred Strains; Atomoxetine Hydrochloride; Attention; Benzimidazoles; Choice Behavior; Dopamine Agonists; Guanfacine; Impulsive Behavior; Male; Methylphenidate; Piperazines; Propylamines; Quinpirole; Rats; Reaction Time; Serial Learning; PharmacologyAnesthesiaDopamine AgonistsImpulsive BehaviorNoradrenalineAtomoxetineMethylphenidateBenzimidazolesmedicine.symptomPsychologyNeuroscience030217 neurology & neurosurgerymedicine.drugAtomoxetine hydrochloride
researchProduct

Changing the General Factor of Personality and the c-fos Gene Expression with Methylphenidate and Self-Regulation Therapy

2012

[EN] A deepening in the biological nature of the general factor of personality (GFP) is suggested: the activation level of the stress system is here represented by the gene expression of c-fos. The results of a single case experimental design are reported. A model of four coupled differential equations that explains the human personality dynamics as a consequence of a single stimulant drug intake has been fitted to psychological and biological experimental data. The stimulant-drug conditioning and its adaptation to the considered mathematical model is also studied for both kinds of measures. The dynamics of the cfos expression presents a similar pattern to the dynamics of the psychological …

MaleLinguistics and LanguageSubjective variablesmedia_common.quotation_subjectGene ExpressionModels PsychologicalHierarchical structure of the Big Fivec-FosDynamic modelLanguage and LinguisticsDevelopmental psychologyTerapia de auto-regulaciónGene expressionConditioning PsychologicalSelf-regulation therapymedicinePersonalityHumansPersonalidadGeneral Psychologymedia_commonModelo dinámicobiologyC-fosMethylphenidateGenes fosMiddle AgedUp-RegulationCoupled differential equationsExpression (architecture)biology.proteinMethylphenidateFactor general de personalidadCentral Nervous System StimulantsGeneral factor of personalityPsychologyMATEMATICA APLICADANeuroscienceProto-Oncogene Proteins c-fosMetilfenidatomedicine.drugPersonality
researchProduct

Differential impact of a multimodal versus pharmacological therapy on the core symptoms of Attention Deficit Hyperactivity Disorder in childhood

2015

Abstract The aim of this study was to analyze the relative and differential efficacy of a combined versus medical treatment to reduce the symptoms of ADHD children in the school and family environment. A total of 100 subjects participated: 20 children with ADHD, their 40 parents and their 40 teachers. Half of the subjects were assigned to the drug group and half to the combined (drug plus psychosocial, psychoeducational intervention with teachers and mothers/fathers). Results The group analyses indicated that both treatments were effective, without significant differences between them. Individualized clinical analyses indicated that higher percentages of improvement and normalization were o…

MaleParentsmedicine.medical_specialtyTrastorns per dèficit d'atenció amb hiperactivitat en els infantsPharmacological therapyeducation.educational_degreePsychological interventionPsychiatric rehabilitationPsychiatric RehabilitationAttention deficit disorder with hyperactivity in children03 medical and health sciences0302 clinical medicinemental disordersDevelopmental and Educational PsychologymedicineCombined Modality TherapyAttention deficit hyperactivity disorderHumans0501 psychology and cognitive sciencesPsychiatryeducationChildDifferential impactAttention-deficit-disordered childrenMethylphenidate05 social sciencesTeacher Trainingmedicine.diseaseCombined Modality TherapyClinical PsychologyTrastorns per dèficit d'atenció en els infantsAttention Deficit Disorder with HyperactivityMethylphenidateCentral Nervous System StimulantsFemaleSchool TeachersPsychologyPsychosocial030217 neurology & neurosurgery050104 developmental & child psychologymedicine.drug
researchProduct

Pharmacological Neuroenhancement: Substances and Epidemiology

2013

Pharmacological neuroenhancement (PN) refers to the general use of psychoactive substances with the purpose of cognitive enhancement (e.g. enhancement of vigilance, concentration, memory or mood) by healthy subjects. Substances for PN include Over-the-Counter- (OTC-) substances such as coffee, caffeinated drinks/energy drinks, caffeine tablets and Ginkgo biloba as well as prescription drugs and illicit drugs (e.g. (psycho-) stimulants). “Brain doping” refers to the illicit use of a subcategory of these substances. On the one hand, this subcategory includes prescription drugs for the treatment of attention deficit/hyperactivity disorder (ADHD), sleep disorders, Alzheimer’s disease and depres…

Methylphenidatebusiness.industryEcstasyModafinilMemantineNeuroenhancementPharmacologychemistry.chemical_compoundMoodchemistrymental disordersmedicineMedical prescriptionCaffeinebusinessmedicine.drug
researchProduct

Systematic review of transdermal treatment options in attention-deficit/hyperactivity disorder: implications for use in adult patients.

2021

Abstract Background Adults with attention-deficit/hyperactivity disorder (ADHD) often face delays in diagnosis and remain untreated, despite significant negative impacts. To evaluate the safety and efficacy of transdermal treatment options in children, adolescents, and adults, a systematic literature review was conducted, with a focus on the implications of transdermal therapies for ADHD in adults. Methods A MEDLINE/Embase/BIOSIS/SCOPUS database search was conducted December 4, 2019, for English-language articles of interventional clinical trials using transdermal formulations for the treatment of ADHD without publication date limit. Assessed outcomes included efficacy, safety, adherence, a…

Pediatricsmedicine.medical_specialtyMethylphenidatebusiness.industrymedicine.diseaseDiscontinuationClinical trialPsychiatry and Mental healthSystematic reviewQuality of lifemedicineAttention deficit hyperactivity disorderNeurology (clinical)Adverse effectbusinessTransdermalmedicine.drugCNS spectrums
researchProduct

Effectiveness and safety of dexamphetamine sulfate (Attentin

2021

Abstract Background: Randomized controlled trials have shown that dexamphetamine sulfate (DEX) is efficacious in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents; however, data on the effectiveness and safety of DEX in routine practice are scarce. Objective: This study investigated the long-term effectiveness and safety of Attentin® (immediate-release DEX) in children and adolescents with ADHD in routine practice. Methods: ATTENTION was a multicenter, prospective, observational, non-interventional study that enrolled pediatric patients with ADHD (aged 6-17 years) with a clinically inadequate response to previous methylphenidate (MPH) treatment. Pa…

Pediatricsmedicine.medical_specialtydexamphetamineRC435-571Impulsivitylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialchildrenlawRating scale030225 pediatricsmental disordersmedicineClinical endpointADHDPsychology0501 psychology and cognitive sciencesadolescentsPsychiatryMethylphenidatebusiness.industry05 social sciences3. Good healthBF1-990Blood pressureMedicineObservational studyOnset of actionmedicine.symptombusiness050104 developmental & child psychologymedicine.drugScandinavian journal of child and adolescent psychiatry and psychology
researchProduct

The effects of castration and of progestin-oestrogen combinations upon avoidance condtioning in female rats

1970

Summary Using avoidance conditioning the authors show that female rats, three months after castration, emit a lower number of responses. Isolation has no effect whatever on rats, whether normal or castrated. Brief treatment with progestin-oestrogen combinations, interrupted 60 hours before the commencement of the session, brings the behaviour of castrated rats back to the norm. Identical effects occur with the use of a cortical stimulating drug (methylphenidate); while, the action of this drug soon ceases, the effect of hormonal treatment lasts for the duration of the experiments. The results are discussed with reference to the significance to be attributed to the experiments.

Pharmacologymedicine.medical_specialtyMethylphenidatemedicine.drug_classAvoidance Conditioningchemistry.chemical_compoundCastrationEndocrinologychemistryInternal medicinemedicineBrief treatmentPsychologyProgestinHormonemedicine.drugPharmacological Research Communications
researchProduct